BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25797191)

  • 1. Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil.
    da Silva NM; Germano FN; Vidales-Braz BM; Carmo Zanella Rd; dos Santos DM; Lobato R; de Martinez AM
    Cytokine; 2015 Jun; 73(2):253-7. PubMed ID: 25797191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan.
    Afzal MS; Tahir S; Salman A; Baig TA; Shafi T; Zaidi NU; Qadri I
    J Infect Dev Ctries; 2011 Jul; 5(6):473-9. PubMed ID: 21727647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
    Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
    J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.
    Sheneef A; Esmat MM; Mohammad AN; Mahmoud AA; Moghazy HM; Noureldin AK
    J Interferon Cytokine Res; 2017 Apr; 37(4):175-180. PubMed ID: 28387594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection.
    El-Karaksy HM; Sharaf SA; Mandour IA; Mogahed EA; Rady NH; El-Mougy FA
    Hum Immunol; 2016 Dec; 77(12):1248-1253. PubMed ID: 27660094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C.
    Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Gartung C; Lorenzen J; Matern S; Lammert F
    Hepatology; 2004 Aug; 40(2):327-34. PubMed ID: 15368437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms in the first exon of mannose binding lectin gene (MBL2) in Brazilian patients with HCV infection.
    Segat L; Silva Vasconcelos LR; Montenegro de Melo F; Santos Silva B; Arraes LC; Moura P; Crovella S
    Clin Immunol; 2007 Jul; 124(1):13-7. PubMed ID: 17513174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of IL-17 polymorphisms and serum levels in patients with chronic HCV infection].
    Nan YM; Zhang YG; Kong LB; Zheng HW; Sun DX; An CM; Li YS; Li CY; Kong L; Dai EH; Tong LX; Zhao SX; Su SS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):425-8. PubMed ID: 24034842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.
    Mueller T; Mas-Marques A; Sarrazin C; Wiese M; Halangk J; Witt H; Ahlenstiel G; Spengler U; Goebel U; Wiedenmann B; Schreier E; Berg T
    J Hepatol; 2004 Oct; 41(4):652-8. PubMed ID: 15464247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
    Shaker OG; Abdel-Rahim MT; Bayoumi ST
    Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients.
    Jiménez-Sousa MA; Rallón N; Berenguer J; Pineda-Tenor D; López JC; Soriano V; Guzmán-Fulgencio M; Cosín J; Retana D; García-Álvarez M; Miralles P; Benito JM; Resino S
    J Clin Virol; 2015 Apr; 65():62-7. PubMed ID: 25766991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients.
    Fragoso JM; Vallejo M; Alvarez-León E; Delgadillo H; Peña-Duque MA; Cardoso-Saldaña G; Posadas-Romero C; Martínez-Ríos MA; Vargas-Alarcón G
    Cytokine; 2011 Jul; 55(1):29-33. PubMed ID: 21481602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients.
    Yang AM; Wen LL; Yang CS; Wang SC; Chen CS; Bair MJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):291-8. PubMed ID: 24835349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relations between IL-2-330 polymorphisms and the outcome of hepatitis B and/or hepatitis C virus infection].
    Gao QJ; Liu DW; Zhang SY; Wu LH; Jia M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1041-5. PubMed ID: 21162873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection.
    Mangia A; Santoro R; Piattelli M; Pazienza V; Grifa G; Iacobellis A; Andriulli A
    Cytokine; 2004 Feb; 25(3):103-9. PubMed ID: 14698136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3.
    Suneetha PV; Goyal A; Hissar SS; Sarin SK
    J Med Virol; 2006 Aug; 78(8):1055-60. PubMed ID: 16789008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.
    Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
    Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection.
    Abbas OM; Abdel-Rahman MH; Omar NA; Badran HM; Amir EM
    Liver Int; 2009 Oct; 29(9):1422-30. PubMed ID: 19555400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study.
    Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Pineda-Tenor D; Aldámiz-Echevarria T; García-Broncano P; Carrero A; García-Álvarez M; Tejerina F; Diez C; Vazquez-Morón S; Resino S
    J Transl Med; 2015 Jun; 13():206. PubMed ID: 26123260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.